Zhejiang Wolwo Stock Hits Day High with Strong 4.39% Intraday Surge

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. has shown significant activity today, with the stock rising by 4.39% as of March 18, 2026. The stock reached an intraday high of CNY 26.58, reflecting a strong performance compared to the China Shanghai Composite, which increased by only 0.32% on the same day. Over the past week, Zhejiang Wolwo has outperformed the broader market, gaining 5.87%, while the Shanghai Composite declined by 1.7%. However, the stock has faced challenges over the longer term, with a year-to-date performance of -7.69% and a three-year decline of 49.01%. Despite these setbacks, the company has demonstrated resilience, achieving an 18.42% increase over the past year, closely aligning with the Shanghai Composite's performance of 18.46%. Financially, Zhejiang Wolwo boasts a market capitalization of CNY 12,510 million and a return on equity of 14.15%. The company maintains a solid operating cash flow and a favorable interest coverage ratio, indicating a stable financial position. With a dividend yield of 0.92%, the stock remains an intriguing option within the pharmaceuticals and biotechnology sector.